Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Alzheimer's Disease Diagnosis & Treatments -

Alzheimer's Disease Diagnosis & Treatments

Marisa R Boyd (Herausgeber)

Buch | Hardcover
298 Seiten
2011
Nova Science Publishers Inc (Verlag)
978-1-61122-064-3 (ISBN)
CHF 259,10 inkl. MwSt
  • Versand in 10-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD). This title presents research in the study of Alzheimer's Disease, including diagnosis, testing and treatment of this condition.
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The course the disease takes and the speed at which changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. This book presents research in the study of Alzheimer's Disease, including diagnosis, testing and treatment of this condition.

Preface; Alzheimers Disease -- 100 Years of Research: A Historical Perspective & Commentary; Controlled & Automatic Memory Processing in Alzheimers Disease; Age of Onset Related Differences in Clinical & Neuropsychological Features of Alzheimers Disease; Early Onset Dementia with Abundant Non-Neuritic Ass Plaques & without Significant Neuronal Loss: Report of Two Japanese Autopsy Cases; How & Where Does Ass Exert its Toxic Effects in Alzheimers Disease?; The Spatial Patterns of ss-Amyloid (Ass) Deposits & Neurofibrillary Tangles (NFT) in Late-Onset Sporadic Alzheimer's Disease; Brain Function in Altered States of Consciousness: Comparison between Alzheimer Dementia & Vegetative State; Cognitive Deficits in Mild Cognitive Impairment; Mitochondrial Pathology & Alzheimers Disease; Calmodulin Binds to & Regulates the Activity of Beta-Secretase (BACE1); Transgenic Models of Alzheimers Pathology: Success & Caveats; Relevance of COX-2 Inhibitors in Alzheimers Disease; Copper Studies in Alzheimers Disease; Theoretical Comparison of Copper Chelators as Anti-Alzheimer & Anti-Prion Agents; Toward a More Rational Approach to the Treatment of Patients with Dementia with Psychosis & Behavioral Disturbance; Amyloid Clearing Immunotherapy for Alzheimers Disease & the Risk of Cerebral Amyloid Angiopathy; Use of Antidepressants in Older People with Mental Illness; A Systematic Study of Tolerability & Use in Different Diagnostic Groups; Cystatin C Role in Alzheimer Disease: from Neurodegeneration to Neuroregeneration; A Theoretical Evaluation on Acetylcholinesterase-Inhibitory Potential of Quercetin; Therapy with Drug Product AZD-103 May Ease Alzheimer's Disease; NSAIDs in Animal Models of Alzheimer's Disease; Index.

Zusatzinfo Illustrations
Verlagsort New York
Sprache englisch
Maße 260 x 180 mm
Gewicht 758 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
ISBN-10 1-61122-064-5 / 1611220645
ISBN-13 978-1-61122-064-3 / 9781611220643
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gisela Mötzing; Susanna Schwarz

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 46,15
das gesamte Spektrum der Altersmedizin für Klinik und Praxis

von Jürgen M. Bauer; Clemens Becker; Michael Denkinger

Buch | Hardcover (2024)
Kohlhammer (Verlag)
CHF 259,95
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Klaus Hager; Olaf Krause

Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
CHF 51,80